The potential for Social Media (#SoMe) to contribute to HIV prevention is worth exploring and researching but studies need to be conducted with strict criteria to discern the evidence from the hype in such a fuzzy area. A study published in the Annals of Internal
2011, the year of PrEP. In less than 18 months 6 clinical trials investigating the potential use of HIV antiretrovirals (ARV) for the prevention of HIV acquisition have rocked the HIV prevention world. First it was the South African CAPRISA announcing in July 2010
Closure of oral Tenofovir arm in VOICE Pre-Exposure Prophylaxis trial: PrEP as a “niche intervention”?
The Microbicides Trial Network (MTN) announced yesterday that its VOICE (Vaginal and Oral Interventions to Control the Epidemic, MTN003) HIV Pre-Exposure Prophylaxis (PrEP) prevention study will discontinue the daily oral tenofovir arm of the trial. The decision follows an interim review of the trial’s data
Roger J. Tatoud (Updated 18 May 2011) – Another month and another HIV prevention trial ending prematurely; but this time it is because the study was showing very encouraging outcomes. The trial named HPTN052 and conducted by the HIV Prevention Trial Network was designed to
After years of limited and fragile successes in preventing new HIV infections, it is now recognised that one-size fits all approaches do not work and that only a combination of prevention strategies can bring the HIV epidemic under control. As a result, the concept of